According to the health department data, a total of 44,777 tests were conducted in Karachi over the past seven days. Of them, 7,580 came positive. Reuters/File
KARACHI: A health crisis driven by the Delta variant the most dangerous and transmissible form of the coronavirus to date has emerged in the city ahead of Eidul Azha with sudden increase in Covid-19 positive cases over the past few days.
Sources told
Dawn the patients’ growing number had burdened major tertiary care hospitals where Covid-19 units were almost full to their capacity. A few hospitals were simply refusing to admit patients on grounds that they were out of space.
God have mercy on us : Hospitals in Karachi reaching capacity as Delta variant spreads - Pakistan dawn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dawn.com Daily Mail and Mail on Sunday newspapers.
Delta variant predominantly found in Karachi
July 16, 2021
KARACHI: The National Institute of Health (NIH), Islamabad, has started approaching various institutions performing genome sequencing of Coronavirus throughout the country to become part of a national consortium for sharing their data research, while experts in Karachi claimed to have found out some ‘unidentified variants’ following genotyping of 94 randomly selected SARS-COV-2 samples.
“We have approached around eight to 10 institutions, conducting partial or whole genome sequencing of SARS-COV-2 or Coronavirus and offered them to join research and share data with each other,” an official of the National Institute of Health (NIH), Islamabad, told The News on Thursday. The official said in addition to the NIH, Islamabad, there were some institutions that have the capacity to perform partial or complete genome sequencing of the SARS-COV-2 but added they were not sharing their research and data with each other. “
COVID-19: NIH planning national consortium for data sharing geo.tv - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geo.tv Daily Mail and Mail on Sunday newspapers.
July 11, 2021
Pakistan has earned $10 million by conducting first-ever Phase-III clinical trials for the single-dose Chinese Covid-19 vaccine CanSino Bio at five leading public and private health facilities in the country, and now the National Institute of Health (NIH) is going to earn 30 million dollars within a year by co-manufacturing the same vaccine after technology transfer from China, officials said on Saturday.
“Phase-III clinical trials of the CanSino Biologics single-dose Covid-19 were the first-ever such trials conducted in Pakistan and we earned $10 million by conducting these trials at five centres in Karachi, Lahore and Islamabad. Now we are being approached by companies from the UK, Korea and Japan, as well as from China for conducting Phase-III clinical trials of several more vaccines, which can earn us huge revenue and foreign exchange,” said Major General Aamer Ikram, executive director of the National Institute of Health Islamabad, at a health conference in